Nanosonics Cuts Share Count with On-Market Buy-Back Cancellation

Nanosonics Limited ( (AU:NAN) ) has provided an update.

Nanosonics Limited has reduced its issued capital following the cancellation of 4,575,087 ordinary fully paid shares on 21 February 2026. The cancellation was executed via an on-market share buy-back, indicating active capital management and potentially signalling confidence in the company’s valuation to shareholders.

The buy-back and subsequent share cancellation lower the number of shares on issue, which can enhance earnings per share and may support the share price over time. This move reflects a disciplined approach to balance sheet optimisation and returns to investors, aligning with common capital management practices among established ASX-listed healthcare and technology companies.

The most recent analyst rating on (AU:NAN) stock is a Buy with a A$5.55 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.

More about Nanosonics Limited

Nanosonics Limited is a medical technology company listed on the ASX under the code NAN. The company develops and supplies infection prevention products, with a focus on advanced disinfection systems for healthcare environments and related clinical settings.

Average Trading Volume: 794,362

Technical Sentiment Signal: Sell

Current Market Cap: A$1.12B

Learn more about NAN stock on TipRanks’ Stock Analysis page.